ConductScience.org, home

Paper20737263

Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography.

Alexanderson E and 8 others. J Nucl Cardiol, 2010. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography. Papers, record 20737263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20737263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography.
PubMed
Journal
J Nucl Cardiol
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.36
iCite
Revised in PubMed
2024-01-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alexanderson EErick
2García-Rojas LLeonardo
3Jiménez MMoisés
4Jácome RRodrigo
5Calleja RRodrigo
6Martínez AAlfonso
7Ochoa JMJuan M
8Meave AAloha
9Alexanderson GGraciela

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmmoniaMajor topic
AzetidinesMajor topic
DyslipidemiasMajor topic
Endothelium, VascularMajor topic
Nitrogen IsotopesMajor topic
Positron-Emission TomographyMajor topic
SimvastatinMajor topic
Adenosine
Adolescent
Adult
Aged
Anticholesteremic Agents
Case-Control Studies
Ezetimibe
Female
Humans
Male
Middle Aged
Myocardium
Prospective Studies
Risk Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in20963538Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve.https://conductscience.org/library/papers/20963538

Source PubMed

Download CSV of comments and corrections

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115643116
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.
J Hypertens2005https://conductscience.org/library/papers/15643116PubMed
212505224Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.J Am Coll Cardiol2002https://conductscience.org/library/papers/12505224PubMed
37674504Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification.JAMA1995https://conductscience.org/library/papers/7674504PubMed
46978059
Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography.
Am J Cardiol1982https://conductscience.org/library/papers/6978059PubMed
58653869Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans.Circulation1996https://conductscience.org/library/papers/8653869PubMed
615862426Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events.J Am Coll Cardiol2005https://conductscience.org/library/papers/15862426PubMed
71516170Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging.Circulation1992https://conductscience.org/library/papers/1516170PubMed
818754405[Endothelial function assessment by positron emission tomography in patients with hypercholesterolemia].Arch Cardiol Mex2008https://conductscience.org/library/papers/18754405PubMed
98640974Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques.Circulation1996https://conductscience.org/library/papers/8640974PubMed
1015007110Intensive versus moderate lipid lowering with statins after acute coronary syndromes.N Engl J Med2004https://conductscience.org/library/papers/15007110PubMed
119603539Prediction of coronary heart disease using risk factor categories.Circulation1998https://conductscience.org/library/papers/9603539PubMed
1212485966Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation2002https://conductscience.org/library/papers/12485966PubMed
137842452Role of positron emission tomography in the investigation of human coronary circulatory function.Cardiovasc Res1994https://conductscience.org/library/papers/7842452PubMed
148044952Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography.Circulation1994https://conductscience.org/library/papers/8044952PubMed
153773199
Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).
JAMA1986https://conductscience.org/library/papers/3773199PubMed
1615909736[Evaluation of coronary flow by means of PET in the Mexican population without coronary artery disease].Arch Cardiol Mex2005https://conductscience.org/library/papers/15909736PubMed
1712423708Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.Am J Cardiol2002https://conductscience.org/library/papers/12423708PubMed
188149518
Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.
Circulation1994https://conductscience.org/library/papers/8149518PubMed
1910872616The Framingham Study: ITS 50-year legacy and future promise.J Atheroscler Thromb2000https://conductscience.org/library/papers/10872616PubMed
201934373Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis.Circulation1991https://conductscience.org/library/papers/1934373PubMed

See all 33 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
38534331Low Density Lipoprotein Cholesterol Decreases the Expression of Adenosine A2A Receptor and Lipid Rafts-Protein Flotillin-1: Insights on Cardiovascular Risk of Hypercholesterolemia.Cells2024https://conductscience.org/library/papers/38534331PubMed
30886968Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome.BMC Rheumatol2018https://conductscience.org/library/papers/30886968PubMed
24116351Synthesis and in vivo evaluation of an (18)F-labeled glycoconjugate of PD156707 for imaging ETA receptor expression in thyroid carcinoma by positron emission tomography.Am J Nucl Med Mol Imaging2013https://conductscience.org/library/papers/24116351PubMed
23764095Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X.JACC Cardiovasc Imaging2013https://conductscience.org/library/papers/23764095PubMed
22714648Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease.J Nucl Cardiol2012https://conductscience.org/library/papers/22714648PubMed
20963538Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve.J Nucl Cardiol2010https://conductscience.org/library/papers/20963538PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20737263

GET https://conductscience.org/api/papers/v1/20737263/references?page=2